IL214127A0 - Vaccine compositions - Google Patents

Vaccine compositions

Info

Publication number
IL214127A0
IL214127A0 IL214127A IL21412711A IL214127A0 IL 214127 A0 IL214127 A0 IL 214127A0 IL 214127 A IL214127 A IL 214127A IL 21412711 A IL21412711 A IL 21412711A IL 214127 A0 IL214127 A0 IL 214127A0
Authority
IL
Israel
Prior art keywords
vaccine compositions
vaccine
compositions
Prior art date
Application number
IL214127A
Other languages
English (en)
Original Assignee
Agirx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agirx Ltd filed Critical Agirx Ltd
Publication of IL214127A0 publication Critical patent/IL214127A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001116—Receptors for cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001136—Cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL214127A 2009-01-16 2011-07-17 Vaccine compositions IL214127A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09000610 2009-01-16
PCT/EP2010/000253 WO2010081738A1 (en) 2009-01-16 2010-01-18 Vaccine compositions

Publications (1)

Publication Number Publication Date
IL214127A0 true IL214127A0 (en) 2011-08-31

Family

ID=42133690

Family Applications (1)

Application Number Title Priority Date Filing Date
IL214127A IL214127A0 (en) 2009-01-16 2011-07-17 Vaccine compositions

Country Status (4)

Country Link
EP (1) EP2387415A1 (de)
AU (1) AU2010205782A1 (de)
IL (1) IL214127A0 (de)
WO (1) WO2010081738A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110009095A (ko) 2008-03-03 2011-01-27 더 유니버시티 오브 마이애미 동종 이계 암 세포-기반 면역 요법
JP2011515399A (ja) 2008-03-20 2011-05-19 ユニバーシティー オブ マイアミ 熱ショックタンパクｇｐ９６ワクチン接種及びそれを用いた方法
CN102883746A (zh) * 2010-05-21 2013-01-16 迈阿密大学 癌症治疗
EP2992898A1 (de) * 2014-09-04 2016-03-09 Klinikum rechts der Isar der Technischen Universität München T-Zell-Adjuvant und dessen Verwendung zur therapeutischen und prophylaktischen Impfung
WO2020106843A1 (en) * 2018-11-20 2020-05-28 Innovative Cellular Therapeutics Holdings, Ltd. Modified cell expressing therapeutic agent and uses thereof
US12076343B2 (en) 2020-02-19 2024-09-03 Innovative Cellular Therapeutics Holdings, Ltd. Engineered safety in cell therapy
US12043654B2 (en) 2020-06-02 2024-07-23 Innovative Cellular Therapeutics Holdings, Ltd. Anti-GCC antibody and CAR thereof for treating digestive system cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19608813C2 (de) 1996-03-07 1998-07-02 Angewandte Gentechnologie Syst Konjugat zur Beeinflussung von Wechselwirkungen zwischen Proteinen
IL122818A0 (en) 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
DE10107737A1 (de) * 2001-02-16 2002-09-05 S Rose John Christian Albrecht Verwendung eines Konjugats aus IL-6 und einem IL-6 Rezeptor zur Tumortherapie
EP1598364A1 (de) * 2004-05-21 2005-11-23 AGIRx Limited Chimerischer löslicher Hyper IL-11 Rezeptor und dessen Verwendung
WO2009095033A1 (en) * 2008-01-31 2009-08-06 Agirx Limited Vaccine compositons

Also Published As

Publication number Publication date
WO2010081738A1 (en) 2010-07-22
AU2010205782A1 (en) 2011-09-08
EP2387415A1 (de) 2011-11-23

Similar Documents

Publication Publication Date Title
IL217008A0 (en) Vaccine
IL217949A0 (en) Pesticdal compositions
EP2488022A4 (de) Zusammensetzungen
ZA201109176B (en) Homeglobin compositions
GB0913681D0 (en) Immunogenic composition
GB0906515D0 (en) Fungical compositions
IL219891B (en) Lipopeptide preparations
IL242592A (en) Immunogenic compounds
ZA201109312B (en) Compositions
GB201015132D0 (en) Vaccine composition
EP2402032A4 (de) Immunogene zusammensetzung
GB201006165D0 (en) Vaccine
IL214127A0 (en) Vaccine compositions
EP2252326A4 (de) Impfstoffzusammensetzungen
EP2498815A4 (de) Impfstoffzusammensetzung
IL216102A0 (en) Combined measles-malaria vaccine
GB0913680D0 (en) Immunogenic composition
EP2485807A4 (de) Sonnenschutzzusammensetzungen
GB201000522D0 (en) Vaccine
GB0905165D0 (en) Compositions
IL220308A0 (en) Vaccine compositions
IL217194A0 (en) Vaccine
EP2475712A4 (de) Initiatorverstärkte zusammensetzungen
GB0908963D0 (en) Compositions
GB0900943D0 (en) Vaccine compositions